Last updated 2026-07-20
- Raised $1.4M convertible note, Sep 2021
- Raised $1.3M Seed round led by ExitValley, Dec 2019
- Raised $1M Pre-Seed round led by Sanara Ventures, Mar 2018
Total raised
$3.7M
Last: Undisclosed Round 2021-10
Stage
Pre-Seed
Founded
2018
Headcount
500+
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
IMedis develops an AI-driven cloud-based quality management system for radiology departments. The solution aggregates and analyzes data from PACS and RIS to identify and address failure points throughout the radiology workflow, aiming to reduce risk, improve financial efficacy, and create new business opportunities. Their first commercially available module, Duali-Q, manages and follows up on errors of omission in CT scans of the chest and abdomen, and has been shown to increase detection rates of life-threatening diseases by 13%.
Funding history · 3 rounds · $3.7M total
2021-09
Convertible Debt
$1.4M
2019-12
Seed
$1.3M
★ ExitValley
2018-03
Pre-Seed
$1.0M
★ Sanara Ventures
Headcount over time
From 6 (2018-10) to 1,119 (2026-03) · +1,113 (+18550%) · 11 points · source: Finder history + radar grounding
Q&A
- What is IMedis's primary focus?
- IMedis develops an AI-powered Quality Assurance Platform for Radiology, aiming to provide a comprehensive quality management system for radiology departments.
- When was IMedis founded?
- IMedis was founded in January 2018.
- What is IMedis's flagship product?
- Duali-Q is IMedis's first commercially available module, designed for the management and follow-up of errors of omission in CT scans of the chest and abdomen.
- Where is IMedis's headquarters located?
- IMedis's headquarters is located in Rehovot, Israel.
- How many employees does IMedis have?
- IMedis has over 500 employees.
- What was IMedis's most recent funding round?
- IMedis raised $1,400,000 in October 2021.
- What is the total amount of funding IMedis has raised to date?
- IMedis has raised a total of $3,700,000.
- Who are the co-founders of IMedis?
- The co-founders of IMedis are Aviel Blumenfeld, who serves as CEO, and Yitzi Pfeffer, who serves as CTO.
- In which countries is IMedis's Duali-Q module currently in use?
- Duali-Q is currently in use by teaching hospitals in the United States, United Kingdom, and Israel.
Team · 2
Aviel Blumenfeld
Founder · Co-founder & CEO
Yitzi Pfeffer
Founder · Co-founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningComputer VisionNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
deep-learningmachine-visionradiologynatural-language-processingimaginghospitalsartificial-intelligencect-scanhealthcare-providersdigital-healthcaremachine-learningcardiovascularquality-controlpatent-pendingqa
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | imedis.ai/ |
|---|---|
| linkedin.com/company/11298508 |
Identifiers & details
| Legal name | IMedis AI Ltd. |
|---|---|
| Founded | 2018-1 |
| Employees (exact) | 1037 |
| Offices | New York |
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | imedis.ai |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515774826 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-01-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | זרחין אלכסנדר 13 רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-16 | עדכון חיובים במג~ק |